RETRACTION article
Front. Pediatr.
Sec. Genetics of Common and Rare Diseases
Volume 13 - 2025 | doi: 10.3389/fped.2025.1640136
Retraction: ORMDL3 Promotes Angiogenesis in Chronic Asthma Through the ERK1/2/VEGF/MMP-9 Pathway Author: Frontiers Editorial Office*
Provisionally accepted
- Frontiers Media SA, Lausanne, Switzerland
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Article Title: Retraction: ORMDL3 Promotes Angiogenesis in Chronic Asthma Through the ERK1/2/VEGF/MMP-9 Pathway Author: Frontiers Editorial Office* Frontiers Media SA, Lausanne, Switzerland Content: A Retraction of the Original Research Article:ORMDL3 Promotes Angiogenesis in Chronic Asthma Through the ERK1/2/VEGF/MMP-9 Pathway By Ding Z, Yu F, Sun Y, Jiao N, Shi L, Wan J and Liu Q (2022) ORMDL3 Promotes Angiogenesis in Chronic Asthma Through the ERK1/2/VEGF/MMP-9 Pathway. Front. Pediatr. 9:708555. doi: 10.3389/fped.2021.708555The journal retracts the 16 February 2022 article cited above.Following publication, concerns were raised regarding the integrity of the images in the published figures. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. As a result, the data and conclusions of the article have been deemed unreliable and the article has been retracted.This retraction was approved by the Chief Editors of Frontiers in Pediatrics and the Chief Executive Editor of Frontiers. The authors agree to this retraction.
Keywords: ORMDL3, Angiogenesis, Asthma, VEGF, MMP-9, ORMDL sphingolipid biosynthesis regulator 3
Received: 03 Jun 2025; Accepted: 03 Jun 2025.
Copyright: © 2025 Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Frontiers Editorial Office, Frontiers Media SA, Lausanne, Switzerland
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.